Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis

BACKGROUND: Severe acute exacerbations (AE) of idiopathic pulmonary fibrosis (IPF) are medically untreatable and often fatal within days. Recent evidence suggests autoantibodies may be involved in IPF progression. Autoantibody-mediated lung diseases are typically refractory to glucocorticoids and no...

Descripción completa

Detalles Bibliográficos
Autores principales: Donahoe, Michael, Valentine, Vincent G., Chien, Nydia, Gibson, Kevin F., Raval, Jay S., Saul, Melissa, Xue, Jianmin, Zhang, Yingze, Duncan, Steven R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470587/
https://www.ncbi.nlm.nih.gov/pubmed/26083430
http://dx.doi.org/10.1371/journal.pone.0127771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470587/
https://www.ncbi.nlm.nih.gov/pubmed/26083430
http://dx.doi.org/10.1371/journal.pone.0127771

Ejemplares similares